Other Species / Isoforms
  NF-E2 (human)      LTP 

LTP (Low Throughput Papers) : The number of records in which this modification site was determined using methods other than discovery mass spectrometry.

  HTP 

HTP (High Throughput Papers): The number of records in which this modification site was assigned using ONLY proteomic discovery mass spectrometry.

 
S2-p
______MsPCPPQQS
0 1
NF-E2 (human) ______MsPCPPQQS S2-p
NF-E2 (mouse) ______MPPCPPQQN P2
NF-E2 (rat) ______MPPCPPQPN P2
K108-ub
NMAIPVSkPLSLSGL
Upstream
Downstream
1 0
Effects on Modified Protein
  • protein degradation
  • ubiquitination
Effects on Biological Processes:
  • transcription, inhibited
Treatment
  • MG132
NF-E2 (human) NMAIPVSkPLSLSGL K108-ub
NF-E2 (mouse) NVAIPVSKPLTLSGL K108
NF-E2 (rat) NIAIPVSKPLTLSGL K108
K137-ub
GLPAGPPkPQEDPES
Upstream
Downstream
1 0
Effects on Modified Protein
  • protein degradation
  • ubiquitination
Effects on Biological Processes:
  • transcription, inhibited
Treatment
  • MG132
NF-E2 (human) GLPAGPPkPQEDPES K137-ub
NF-E2 (mouse) GLPVGQPKPQEDPES K137
NF-E2 (rat) GLPVGQPKPQEDPES K137
S157-p
LNYSDAEsLELEGTE
Upstream
Downstream
1 1
Effects on Modified Protein
  • protein degradation
  • ubiquitination
Effects on Biological Processes:
  • transcription, inhibited
Kinase, in vitro:
  • JNK1 (human)
Putative in vivo kinases:
  • JNK1 (human)
Treatment
  • anisomycin
  • SP600125
NF-E2 (human) LNYSDAEsLELEGTE S157-p
NF-E2 (mouse) LNYSDAESLELEGME S157
NF-E2 (rat) LNYSDAESLELEGTE S157
S170
TEAGRRRSEYVEMyP
1 0
NF-E2 (human) TEAGRRRSEYVEMyP S170
NF-E2 (mouse) MEAGRRRsEYVDMYP S170-p
NF-E2 (rat) TEAGRRRSEYVDMYP S170
Y176-p
RSEYVEMyPVEyPyS
0 1
NF-E2 (human) RSEYVEMyPVEyPyS Y176-p
NF-E2 (mouse) RsEYVDMYPVEYPYS Y176
NF-E2 (rat) RSEYVDMYPVEYPYS Y176
Y180-p
VEMyPVEyPySLMPN
0 1
NF-E2 (human) VEMyPVEyPySLMPN Y180-p
NF-E2 (mouse) VDMYPVEYPYSLMPN Y180
NF-E2 (rat) VDMYPVEYPYSLMPN Y180
Y182-p
MyPVEyPySLMPNSL
0 1
NF-E2 (human) MyPVEyPySLMPNSL Y182-p
NF-E2 (mouse) MYPVEYPYSLMPNSL Y182
NF-E2 (rat) MYPVEYPYSLMPNSL Y182
Y194-p
NSLAHSNyTLPAAET
0 1
NF-E2 (human) NSLAHSNyTLPAAET Y194-p
NF-E2 (mouse) NSLAHPNYTLPPTET Y194
NF-E2 (rat) NSLAHPNYTLPPTET Y194
K215-ub
SSGPVRAkPTARGEA
Upstream
Downstream
1 0
Effects on Modified Protein
  • protein degradation
  • ubiquitination
Effects on Biological Processes:
  • transcription, inhibited
Treatment
  • MG132
NF-E2 (human) SSGPVRAkPTARGEA K215-ub
NF-E2 (mouse) SSGPVRAKPAVRGEA K215
NF-E2 (rat) SSGPVRAKPAVRGEA K215
K234-ub
ERRALAMkIPFPTDk
Upstream
Downstream
1 0
Effects on Modified Protein
  • protein degradation
  • ubiquitination
Effects on Biological Processes:
  • transcription, inhibited
Treatment
  • MG132
NF-E2 (human) ERRALAMkIPFPTDk K234-ub
NF-E2 (mouse) ERRALAMKIPFPTDK K234
NF-E2 (rat) ERRALAMKIPFPTDK K234
K241-ub
kIPFPTDkIVNLPVD
Upstream
Downstream
1 1
Effects on Modified Protein
  • protein degradation
  • ubiquitination
Effects on Biological Processes:
  • transcription, inhibited
Treatment
  • MG132
NF-E2 (human) kIPFPTDkIVNLPVD K241-ub
NF-E2 (mouse) KIPFPTDKIVNLPVD K241
NF-E2 (rat) KIPFPTDKIVNLPVD K241
S346-p
DESGNSYsPEEYALQ
Upstream
1 1
Kinase, in vitro:
  • JNK1 (human)
Putative in vivo kinases:
  • JNK1 (human)
Treatment
  • anisomycin
  • SP600125
NF-E2 (human) DESGNSYsPEEYALQ S346-p
NF-E2 (mouse) DESGNSYSPEEYVLQ S346
NF-E2 (rat) DESGNSYSPEEYVLQ S346
K368-ub
FLVPRGTkMEATD__
Upstream
Downstream
1 0
Effects on Modified Protein
  • protein degradation
  • ubiquitination
Effects on Biological Processes:
  • transcription, inhibited
Treatment
  • MG132
NF-E2 (human) FLVPRGTkMEATD__ K368-ub
NF-E2 (mouse) FLVPRGTKMEATD__ K368
NF-E2 (rat) FLVPRGTKMEATD__ K368
K368-sm
FLVPRGTkMEATD__
Downstream
1 0
Effects on Modified Protein
  • molecular association, regulation
Effects on Biological Processes:
  • transcription, induced
NF-E2 (human) FLVPRGTkMEATD__ K368-sm
NF-E2 (mouse) FLVPRGTKMEATD__ K368
NF-E2 (rat) FLVPRGTKMEATD__ K368